Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Pilot Study of Lestaurtinib (CEP-701) in Combination With Chemotherapy in Young Patients With Relapsed or Refractory FLT3-mutant Acute Myeloid Leukemia

NCT00469859 is registered in ClinicalTrials.gov with Children's Oncology Group as lead sponsor.

NCT NCT00469859
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00469859 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Pilot Study of Lestaurtinib (CEP-701) in Combination With Chemotherapy in Young Patients With Relapsed or Refractory FLT3-mutant Acute Myeloid Leukemia
Lead sponsor
Children's Oncology Group
Phase
Phase 1/2
Overall status
Completed
Start date
June 30, 2007
Completion date
March 31, 2010
Enrollment
14 (actual)
Sites
21

Conditions

As the registry lists them; a condition with its own page is linked.

leukemia